Items where Division is "Research Institute for Primordial Prevention of Non-communicable Disease" and Year is 2021
 | Up a level |
Number of items: 1.
(2021) Significant immunomodulatory and hepatoprotective impacts of Silymarin in MS patients: A double-blind placebo-controlled clinicaltrial. Int Immunopharmacol. p. 107715. ISSN 1567-5769